期刊
JOURNAL OF NEURO-ONCOLOGY
卷 123, 期 3, 页码 413-423出版社
SPRINGER
DOI: 10.1007/s11060-015-1747-8
关键词
PD-1; CTLA-4; Immune checkpoint; Glioblastoma multiforme
资金
- NCI NIH HHS [P30 CA006973] Funding Source: Medline
Targeted immunotherapy is founded on the principle that augmentation of effector T cell activity in the tumor microenvironment can translate to tumor regression. Targeted checkpoint inhibitors in the form of agonist or antagonist monoclonal antibodies have come to the fore as a promising strategy to activate systemic immunity and enhance T cell activity by blocking negative signals, enhancing positive signals, or altering the cytokine milieu. This review will examine several immune checkpoints and checkpoint modulators that play a role in cancer pathogenesis, with an emphasis on malignant gliomas.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据